Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes by Lobo, CL et al.
Alterations of the Blood-Retinal Barrier
and Retinal Thickness in Preclinical
Retinopathy in Subjects With Type 2 Diabetes
Conceic¸a˜o L. Lobo, MD, MSc; Rui C. Bernardes, BSc; Jose´ G. Cunha-Vaz, MD, PhD
Objective: To identify alterations of the blood-retinal
barrier by mapping retinal fluorescein leakage into the
vitreous and changes in retinal thickness occurring in the
macular region in preclinical diabetic retinopathy.
Methods: Ten eyes from 10 patients with type 2 diabe-
tes and no lesions visible on fundus photography (level
10 of Wisconsin grading) were examined with the reti-
nal leakage analyzer (RLA) (Confocal Scanning Laser
Ophthalmoscope [modified]; Carl Zeiss Inc, Thorn-
wood, NY) and the retinal thickness analyzer (RTA) (Ta-
lia Technology, Mevaseret Zion, Israel). The maps of reti-
nal leakage and retinal thickness were aligned and
integrated in the same image to correlate leakage with
thickness. Data from the group of individuals with dia-
betes were compared with those of a healthy control popu-
lation (N=14; mean age, 48 years; range, 42-55 years)
and used to establish reference maps for the RLA and RTA.
Results: Areas of abnormally increased fluorescein leak-
age were detected in 9 of 10 eyes examined. The increased
leakage in 6 (67%) of 9 eyes reached values higher than
40% more than the mean +2 SD RLA control value. Areas
of abnormally increased thickness were found in 7 of 10
eyes examined. For the most part, the increases in retinal
thickness were not severe (ie, ,15% increase in 5 eyes and
an 18% increase in 1 eye). The eyes with the most exten-
sive leakage (cases 1, 3, and 9) showed relatively good co-
incidence between the location of the areas of increased leak-
age and the location of the areas of increased thickness. In
4 eyes (cases 2, 5, 7, and 8), no such correlation was ap-
parent. The 3 remaining eyes showed little coincidence be-
tween these locations. Characteristically, the latter 3 eyes
had areas of abnormally increased thickness that were much
larger than the areas of increased fluorescein leakage, which
were relatively moderate or absent of any leakage.
Conclusions: Localized sites of increased fluorescein
leakage and zones of increased retinal thickness were
found in most eyes in a series of 10 eyes in the prereti-
nopathy stage from 10 patients with type 2 diabetes. In-
creases in retinal thickness may be observed that do not
coincide with sites of retinal leakage. Two types of in-
creased retinal thickness may, therefore, be present in the
preretinopathy stage of diabetic retinopathy, one di-
rectly associated with an alteration of the blood-retinal
barrier, and another occurring without apparent break-
down of blood-retinal barrier.
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D IABETIC retinopathy,which often is found inpatients with diabetes, re-mains one of the leadingcauses of visual disabil-
ity and blindness in economically devel-
oped countries. It is a particularly chal-
lenging condition since a sharp increase
in the prevalence and incidence of dia-
betes (especially type 2 diabetes) is ex-
pected in the next decade.
Studies such as the Diabetes Con-
trol and Complications Trial,1 the United
Kingdom Prospective Diabetes Study,2 the
Diabetic Retinopathy Study,3 and the Early
Treatment of Diabetic Retinopathy Study4
validated methods that are now consid-
ered standard in treating diabetic retinopa-
thy. These methods include tight control
of blood glucose levels to prevent reti-
nopathy from worsening, and laser pho-
tocoagulation to halt progression after the
development of clinically significant macu-
lar edema or proliferative retinopathy.
These landmark studies clearly changed
the expected outcomes of diabetic reti-
nopathy by offering better approaches to
its management.
Photocoagulation and good glyce-
mic control are important improvements
in the management of diabetic retinopa-
thy. They are clearly more effective than
what was available 15 years ago. How-
ever, despite the success of these ap-
proaches, preventable blindness still oc-
curs. Photocoagulation offers a relatively
poor treatment alternative because it is a
technique that achieves results by destroy-
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ing the retina. Other forms of therapy, targeted at the ear-
liest stages of retinal disease when the disease process may
still be reversible, are urgently needed.
New methods with which to examine the retina, such
as the retinal thickness analyzer (RTA)5 and the retinal
leakage analyzer (RLA),6 have been recently intro-
duced. These systems are able to measure reproducibly
in a clinical setting changes in the thickness of the retina
and localized alterations of the blood-retinal barrier (BRB).
We have applied these methods to the study of diabetic
eyes with preclinical retinopathy, looking for changes that
may be present before overt ophthalmoscopic retinopa-
thy develops.
RESULTS
Areas of abnormally increased fluorescein leakage were de-
tected in 9 (90%) of 10 eyes examined (Table 3). The in-
creased leakage in 6 (67%) of 9 eyes reached values higher
than 40% more than the mean RLA control + 2 SD. In 5
(56%) of 9 eyes, the areas of increased leakage covered 50%
or more of the retina under examination. In 8 (89%) of 9
eyes, the areas of increased leakage extended to the fovea.
Areas of abnormally increased thickness were found
in 7 (70%) of 10 eyes examined (Table 3). For the most
part, the increases in retinal thickness were not severe
(ie, ,15% in 5 eyes and 18% in 1 eye). One eye with sub-
stantially increased retinal thickness of 50% also had the
most retinal leakage. Areas of increased thickness cov-
ering 50% or more of the retina were found in 4 of 7 eyes
also with increased leakage. In 5 (71%) of 7 cases, the
areas of increased thickness did not involve the fovea.
Increased retinal thickness in the central 500 µm of the
foveola was found in only 2 eyes when the retinal thick-
ening covered most of the retina examined (63% and 100%
increases, respectively) and when intense leakage was as-
sociated. One eye had abnormally increased retinal thick-
ness without associated abnormal increase in leakage. This




Ten eyes from 10 patients (6 men, 4 women; mean age, 54
years; range, 48-58 years) with type 2 diabetes but no evi-
dence of retinopathy on slitlamp examination and stereo fun-
dus photography (level 10 of Wisconsin grading) were ex-
amined with the RLA6 and the RTA7 (Talia Technology Ltd,
Mevaseret Zion, Israel). Their duration of diabetes ranged from
1 to 10 years (mean duration, 5.6 years). Their glycosylated
hemoglobin (HbA1C) value ranged from 0.06 to 0.08 (mean
HbA1C value, 0.067) (Table 1). The patients were included
in a series of patients with type 2 diabetes who had relatively
good metabolic control (HbA1C level , 0.08), between the
ages of 40 and 60 years (similar to a healthy control popu-
lation previously examined with RTA and RLA), and with
blood pressure levels at or below 155/85 mm Hg.
Stereo fundus photography was performed accord-
ing the Early Treatment of Diabetic Retinopathy Study pro-
tocol.4 Stereoscopic pairs of fields were obtained using a
30° fundus camera to classify as level 10.
Tenets of the Declaration of Helsinki were followed, and
the approval of the institutional review board was obtained.
RETINAL LEAKAGE ANALYZER
The RLA is a new method that quantifies localized fluo-
rescein leakage in humans from the retina into the vitre-
ous across the BRB.6
In brief, the instrumentation consists of a confocal scan-
ning laser ophthalmoscope (Carl Zeiss Inc, Thornwood, NY)
that was modified to obtain fluorescence measurements in
the vitreous. Data and images obtained with this instru-
ment are of a 20° field of view that corresponds to a scanned
area 3150 µm wide 3 2700 µm high. To build a map show-
ing the permeability index of the BRB to fluorescein, or a reti-
nal leakage map (RLmap), 2 scans are needed to quantitate
fluorescein into the vitreous. The first scan is taken less than
5 minutes after the intravenous administration of 14 mg/kg
of 20% sodium fluorescein, and the second scan is done 30
minutes after injection. Scans are aligned and the common
areas are processed as previously reported.6
The RLA obtains an image of the fundus with real 3-di-
mensional information. Two types of information are ob-
tained simultaneously, one for optical imaging and one rep-
resenting fluorescence measurements being scanned.
Axial graphics of the fluorescein measurements ob-
tained from the vitreous and representing a volume of
7537532550 µm were converted into RLmaps. Multiple
measurements of retinal leakage can be graphically as-
sembled in a false-color RLmap that represents the distri-
bution of the BRB permeability indices in any chosen area
of the total area of the posterior pole under examination.
Intravisit reproducibility and intervisit reproducibility of
the method are ±10.2% and ±13%, respectively.6
RETINAL THICKNESS ANALYZER
The RTA is a quantitative and reproducible method to evalu-
ate retinal thickness.5 The optical system is similar to that of
a slitlamp biomicroscope, using a helium-neon laser (543 nm)
as the illumination source. The system acquires optical im-
ages of the retina in sections by projecting the laser onto the
retina at an angle, allowing the reflection or scattering of the
laser light from the vitreoretinal and chorioretinal interfaces
to be viewed. The separation between the reflections (and scat-
ter) from these 2 interfaces is a measure of the retinal thick-
ness. The intersection of the laser slit with the retina—the
optical cross-section of the retina—is recorded using a video
camera, then digitized. Each measurement covers a 232-mm
area for a total of 10 optical sections, each separated by 200
µm. Nine scans are performed, covering the central 20° of
the posterior pole. The fundus photograph is obtained si-
multaneously with a separate 60°-field clinical fundus cam-
era. The data are analyzed and the retinal thickness can be
represented as a numerical value or a color-coded map in 2
or 3 dimensions.
The total area scanned with the RTA is 600036000 µm
(30330pixels).Eachpixelrepresentsanareaof2003200µm.
Continued on next page
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Eyes with extensive leakage (cases 1, 3, and 9) showed
relatively good coincidence between the location of the ar-
eas of increased leakage and the location of the areas of in-
creased thickness (Figure 3). In 4 eyes (cases 2, 5, 7, and
8) no such correlation was apparent (Table 2). The 3 re-
maining eyes (cases 4, 6, and 10) showed little coinci-
dence between these locations (Figure 4).
Two of these latter 3 eyes had areas of abnormally
increased thickness much larger than the areas of in-
creased fluorescein leakage, which were relatively mod-
erate. Furthermore, the center of the fovea was spared in
all of these eyes and the increase in retinal thickness re-
mained outside a 500-µm radius centered on the foveola.
COMMENT
Localized sites of increased fluorescein leakage and zones
of increased retinal thickness were found in most eyes
in a series of 10 eyes in the preretinopathy stage from 10
patients with type 2 diabetes. The diabetes in this group
of patients was reasonably well controlled (average HbA1C
value, 0.07).
Abnormal increases in fluorescein leakage were pres-
ent in 90% of examined eyes and abnormal increases in
Table 1. Characteristics of Diabetic Population in Study
Patient No. Age, y
Duration
of Diabetes, y HbA1C
Blood Pressure,
mm Hg
1 56 5 7.0 140/70
2 51 4 4.9 140/80
3 53 7 6.0 150/70
4 54 6 7.4 140/70
5 48 5 7.9 120/80
6 58 7 6.1 150/85
7 53 2 5.5 140/80
8 55 1 7.6 130/80
9 55 9 6.9 120/70
10 56 10 7.4 155/85
DATA ANALYSIS
Data from the group of individuals with diabetes were com-
pared with those of a healthy control population (N=14; mean
age, 48 years; range 42-55 years) used to establish reference
maps for the RLA and RTA (Figure 1 and Figure 2).
Owing to differences in resolution between the RLA
and RTA, a value of leakage is obtained for an area of 75375
µm, while a single value of thickness covers an area of
2003200 µm. Therefore, the smallest area that can be con-
structed that contains integer numbers of leakage and thick-
ness values is 6003600 µm (ie, 838 values of leakage and
333 values of thickness).
To compare information from both the RLA and RTA
using the more detailed data from the leakage maps, we chose
areas of 3003300 µm. The maps, therefore, are composed
of 63 (9 3 7) values, each representing an area of 3003300
µm, for a total of 270032100 µm. For each 3003300 µm area,
the value of leakage is the mean and SD of 16 (4 3 4) values.
To obtain a value of thickness for an equivalent area of
300 3 300 µm, we performed a 2-step procedure. First, val-
ues of thickness were computed as the mean and SD of 9
(333) values, corresponding to an area 600 3 600 µm. Af-
terward, this area is split into 4 adjacent areas of 300 3 300
µm, and the mean and SD values obtained for the 600 3 600
µm area are now given to each of these 4 adjacent areas.
In this healthy control population, the mean values
of the 63 mean values for leakage and thickness are 21.29
3 10−7 cm per second and 168.13 µm, respectively.The mean
SDs for leakage and thickness are 6.19 3 10−7 cm per sec-
ond and 22.56 µm, respectively. The relatively large SD for
leakage, registered after averaging 14 RLmaps, is expected
considering the resolution of the system associated with
regional variations in vascular distribution. The center of
the fovea corresponds to the point of intersection of the
thicker central lines in the reference maps. Figures 1 and
2 present reference values for leakage and thickness for the
right eye of the healthy control population. By comparing
values from the patients with those of the controls, we can
now compute maps of increased leakage or increased thick-
ness as percentages.
All of the increases are computed considering the ref-
erence mean +2 SD. For instance, if a particular area of the
sample population has a mean value of 150 and an SD of
15, the computed limit is 150 +2 3 15=180. For that par-
ticular area, a value of 207 would represent an increase of
15% over the reference value.
Both the grid and the circles depict the relative posi-
tions of the morphological structures, the permeability in-
dex shown in the RLmaps, and the retinal thickness shown
in the RTA maps.
With these methods, we are able to identify and quan-
titate sites of increased leakage and increased thickness and
measure their distance from the fovea.
To compute the distance from the fovea of altered ar-
eas (areas of either increased leakage or increased thick-
ness), we have taken into account that the resolution of the
RLmap is more than 7 times the resolution of the thick-
ness map. For leakage, we have considered the distance in
microns from the center of the fovea to the nearest corner
of an altered area.
For thickness, the minimum distance of an altered area
is computed as the distance in microns from the center of
the fovea to the center of the altered area.
Correlations were established between the location and
severity of the abnormal increases in both maps.
To compute “areas of coincidence” and “areas of no
coincidence” we have to consider 4 possible situations: (1)
for a particular area there are alterations both in leakage
and in thickness (area of coincidence); (2) for a particular
area there is an alteration in leakage but not in thickness
(area of no coincidence); (3) for a particular area there is
an alteration in thickness but not in leakage (area of no co-
incidence); and (4) for a particular area there is no alter-
ation either in leakage or in thickness.
For patients in whom there is an alteration in leak-
age, thickness, or both that covers the entire map, the sum
of cases 1, 2, and 3 is 100% (patient 3, Table 2). For the
other patients, for whom there are areas of neither in-
crease in leakage nor in thickness, the sum of the same cases
(1, 2, and 3) is less than 100%, and the sum for all pos-
sible situations (1, 2, 3, and 4) is 100%.
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retinal thickness were found in 70% of the eyes exam-
ined, even though no other abnormalities were visible
in the retina or detected by ophthalmoscopy or 7-field
stereo fundus photography.
The increases in fluorescein leakage were, in general,
marked with sites reaching values 80% above normal mean
+ 2 SD values obtained from a healthy control population
within a similar age range. Most eyes with increases in reti-
nal thickness were about 15% above the normal mean + 2
SD values registered in the control population.
These findings have clear clinical value, since in-
creased retinal fluorescein leakage identifies an alter-
ation of the BRB and increased retinal thickness charac-
terizes the presence of retinal edema. Retinal edema, the
major cause of visual loss in people with type 2 diabe-
tes,8 has been often associated in the retina with an al-
teration of the BRB. In our study, this finding occurred
in only 6 of 10 eyes examined, and only when the alter-
ation of the BRB was most marked. In the other 4 eyes,
however, there was no direct correlation between the
36 34 34 31 29 29 30 34 36
36 33 34 33 31 29 28 33 32
31 34 34 33 29 28 30 33 35
29 31 37 33 25 25 28 32 36
35 38 38 35 31 26 30 32 40
32 35 36 36 37 33 36 37 41
30 37 42 39 39 40 39 40 44
Figure 1. Retinal leakage analyzer reference map (310−7 cm per second).
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217 217 205 205 191 191 206 206 227
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212 212 206 206 202 202 214 214 230
Figure 2. Retinal thickness analyzer reference map (310−7 cm per second).












1 48 47 31 16
2 0 3 3 0
3 96 4 0 4
4 27 54 10 44
5 0 63 63 0
6 3 36 33 3
7 0 33 0 33
8 0 51 51 0
9 41 56 54 2
10 19 49 6 43
*Areas of coincidence and no coincidence are presented as percentages of the examined area.








% of Examined Area Maximum Increase, %
Distance From
the Fovea, µm
1 79 80 0 63 10 0
2 3 9 670 0 0 . . .
3 96 85 0 100 50 0
4 36 42 0 71 14 600
5 63 71 0 0 0 . . .
6 37 36 0 6 6 1200
7 0 0 . . . 33 9 600
8 51 60 0 0 0 . . .
9 95 87 0 43 8 600
10 25 27 0 62 18 600
*Ellipses indicate not applicable.
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zones of increased retinal thickness and the sites of ab-
normal fluorescein leakage. Furthermore, areas of in-
creased retinal thickness were detected in the absence of
abnormal fluorescein leakage.
Retinal edema should be considered as any in-
crease of water of retinal tissue resulting in an increase
in its volume (ie, thickness). This increase in water con-
tent of the retinal tissue may, as with the brain, be clas-
sified by type as vasogenic or cytotoxic.9 In the first case,
vasogenic edema, the increase is the result of break-
down of the BRB with extracellular deposition of mac-
romolecules. The primary defect is in the BRB and the
accumulation of fluid is extracellular. There is, in this
situation, increased retinal thickness associated with in-
creased fluorescein leakage. The fluorescein leakage it-
self, particularly when examined within 30 minutes af-
ter fluorescein injection, is considered the result of
increased inward BRB permeability rather than owing to
a defective active outward transport.10
The cytotoxic type of edema, extensively de-
scribed and studied in brain abnormalities, has been
associated with excitatory release of glutamate or lac-
tic acidosis and occurs in the absence of barrier break-
down.11 Its presence in the retina in the initial, pre-
clinical stages of diabetic retinal disease is suggested
by our findings, but is still open to question. Alterna-
tive explanations must be considered. Sites of local-
ized retinal edema without an associated site of break-
down of the BRB could represent areas of residual
extracellular edema of the vasogenic type, resulting
from previous leaking sites that have stopped leaking
at the moment of the present examination. Areas of
retinal edema may also result from alterations of the
BRB occurring at relatively distant sites and without
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Area of Leakage (%): 79.37
Maximum % of Increase: 80
Mean % of Increase: 26
Fovea Involvement (100 µm): YES
Fovea Involvement (750 µm): YES
Area of Thickness (%): 63.49
Maximum % of Increase: 10
Mean % of Increase: 4
Fovea Involvement (100 µm): YES
Fovea Involvement (750 µm): YES
% of Thickened Area Without Leakage: 15:87



























Figure 3. Patient 1. Top, Values map. The gray areas represent increased
thickness. Percentages of increase are represented in bold at intersecting
lines. Each value represents 4 adjacent squares. Percentages of increased
leakage are represented by numbers in the squares. Also represented are 2
concentric circles of 100-µm and 750-µm radii centered on the fovea.
Bottom, Same eye with background representing the leakage using a false
color code. Units are 310−7 cm per second. Percentage of increased
thickness is represented in white dots with varying density. The density bar
on the left shows the relation between density and percentage of increase in
thickness. Lines in white represent equal percentage of increase in thickness,
having the corresponding value plotted in red. The black circle is centered on















































Area of Leakage (%): 25.40
Maximum % of Increase: 27
Mean % of Increase: 3
Fovea Involvement (100 µm): YES
Fovea Involvement (750 µm): YES
Area of Thickness (%): 61.90
Maximum % of Increase: 18
Mean % of Increase: 8
Fovea Involvement (100 µm): NO
Fovea Involvement (750 µm): YES
% of Thickened Area Without Leakage: 42:86






Figure 4. Patient 10. Top, Values map. The gray areas represent increased
thickness. Percentages of increase are represented in bold at intersecting
lines. Each value represents 4 adjacent squares. Percentages of increased
leakage are represented by numbers in the squares. Also represented are 2
concentric circles of 100-µm and 750-µm radii centered on the fovea.
Bottom, Same eye with background representing the leakage using a false
color code. Units are 310−7 cm per second. Percentage of increased
thickness is represented in white dots with varying density. The density bar
on the left shows the relation between density and percentage of increase in
thickness. Lines in white represent equal percentage of increase in thickness,
having the corresponding value plotted in red. The black circle is centered on
the fovea with a 750-µm radius.
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an apparent direct correlation. Preferential pathways
for fluid movement may occur in the retina, leading to
accumulation of fluid in particular zones of the retina.
Another alternative explanation for simultaneous
observation in the same retina of areas of coincidence
and areas of no coincidence between sites of leakage
and areas of increased retinal thickness may be derived
from the possibility of varying rates of retinal fluid
reabsorption in areas of extracellular vasogenic edema.
Only a prospective longitudinal study designed to fol-
low in successive visits the sites of breakdown of the
BRB and associated changes in retinal thickness may
clarify these questions.
In summary, this study indicates that in the initial
stages of diabetic retinal disease, breakdown of
the BRB and retinal tissue thickening may occur
simultaneously, either in association with each other
or independently. From this study it is not clear which
occurrence precedes the other. The BRB damage
may modulate and play a role in the development of
retinal tissue thickening, but the opposite is also a
possibility.
Further studies of the natural history of the earli-
est stages of diabetic retinal disease, using new clinical
methods of examination such as the RLA and the RTA
in a prospective fashion, are expected to contribute to
our understanding of the development of diabetic reti-
nopathy.
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